| Nov 1 |
Natera to Report its Third Quarter 2024 Results on November 12, 2024
|
| Oct 31 |
Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
|
| Oct 30 |
Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term
|
| Oct 27 |
Natera: A Genetic Investment Worth Watching And Holding
|
| Oct 23 |
All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy
|
| Oct 22 |
Natera to Present New Renasight Data at ASN Kidney Week 2024
|
| Oct 6 |
Natera Inc. (NTRA): Hedge Funds Are Bullish On This NASDAQ Stock Right Now
|
| Sep 30 |
High Growth Tech Stocks To Watch In September 2024
|
| Sep 24 |
Natera, Inc. (NASDAQ:NTRA) Shares Could Be 23% Above Their Intrinsic Value Estimate
|
| Sep 23 |
Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
|
